Ameriprise’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-101,645
| Closed | -$222K | – | 3960 |
|
2022
Q2 | $222K | Sell |
101,645
-1,092
| -1% | -$2.39K | ﹤0.01% | 3658 |
|
2022
Q1 | $327K | Buy |
102,737
+2,326
| +2% | +$7.4K | ﹤0.01% | 3612 |
|
2021
Q4 | $421K | Buy |
100,411
+43,933
| +78% | +$184K | ﹤0.01% | 3569 |
|
2021
Q3 | $459K | Sell |
56,478
-23,445
| -29% | -$191K | ﹤0.01% | 3430 |
|
2021
Q2 | $604K | Sell |
79,923
-2,109
| -3% | -$15.9K | ﹤0.01% | 3385 |
|
2021
Q1 | $712K | Buy |
82,032
+43,842
| +115% | +$381K | ﹤0.01% | 3277 |
|
2020
Q4 | $305K | Buy |
+38,190
| New | +$305K | ﹤0.01% | 3494 |
|